About 6% of U.S. Adults Have ADHD, Drug Shortages Are Affecting Treatment

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 10, 2024.

By Ernie Mundell HealthDay Reporter

THURSDAY, Oct. 10, 2024 -- More than 15.5 million U.S. adults have been diagnosed with ADHD, and nearly three-quarters of those taking medication to treat it say drug shortages are hampering their ability to get help, a new report finds.

According to the U.S. Centers for Disease Control and Prevention (CDC), a national survey conducted last fall found that 6% of adults have a current diagnosis of attention deficit hyperactivity disorder (ADHD), and just over half (about 56%) received that diagnosis in adulthood.

Many aren't receiving treatment to control the inattention, impulsivity and hyperactivity that characterize the condition.

"Approximately one half of adults (50.4%) with ADHD were prescribed medications to treat their ADHD during the previous 12 months," noted a team led by Brooke Staley of the CDC's National Center on Birth Defects and Developmental Disabilities.

The vast majority of drug treatments involved stimulant medications such as Ritalin, Vyvanse, Concerta or Adderall. However, recent shortages of these meds are affecting most adult ADHD patients, the study also found.

"Among adults who reported taking a stimulant medication, 71.5% reported difficulty getting their ADHD prescription filled during the previous 12 months because their medication was not available," the CDC team said.

That can lead to real problems for patients, because proper medication is tied to "reduced social and emotional impairment, unintentional injuries, substance use disorders, and the risk of death to unnatural causes," the report's authors said.

Folks who can't get their ADHD medications through usual means might also try to buy them off the Internet or elsewhere, "increasing their risk for overdose because of the prevalence of counterfeit pills in the illegal drug market, which might contain unexpected substances such as fentanyl," Staley's team added.

ADHD drug shortages have plagued U.S. patients for years. The FDA first warned of a shortage of Teva Pharmaceutical Industries’ Adderall medication in October 2022, as the company grappled with manufacturing delays.

In September, the U.S. Drug Enforcement Administration gave drugmaker Takeda, the maker of Vyvanse, the green light to make more of the medication as a shortage of ADHD drugs continues.

Telehealth is a relatively new avenue some adults with ADHD might turn to as they seek out needed care.

The new report noted that close to half (46%) of adults with ADHD said they had used such services, including nearly 1 in 10 patients who said they received their ADHD diagnosis via telehealth services.

About 30% said they had gotten help accessing ADHD meds and/or counseling in this way, as well.

The new findings were published Oct. 10 in the CDC journal Morbidity and Mortality Weekly Report.

More information

Find out more about ADHD and its treatment at the National Institute of Mental Health.

SOURCE: Morbidity and Mortality Weekly Report, Oct. 10, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-10-11 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords